<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="336583">
  <stage>Registered</stage>
  <submitdate>23/02/2011</submitdate>
  <approvaldate>28/02/2011</approvaldate>
  <actrnumber>ACTRN12611000213943</actrnumber>
  <trial_identification>
    <studytitle>Evaluation of Maastricht Index(MI) between patients receiving a standard enteral feeding product or kitchen made enteral feeding in an Intensive Care Unit(ICU) of a teaching hospital</studytitle>
    <scientifictitle>a double blind randomized clinical trial to evaluate Maastricht Index (MI) between patients receiving a standard enteral feeding product or kitchen made enteral feeding in an ICU of a  teaching hospital in Iran</scientifictitle>
    <utrn />
    <trialacronym />
    <secondaryid>nil</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>enteral feeding</healthcondition>
    <conditioncode>
      <conditioncode1>Diet and nutrition</conditioncode1>
      <conditioncode2>Other diet and nutrition disorders</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>fresubin (a standard enteral feeding available in Iran) 150 cc every 3 hours via enteral feeding tube for 7 days</interventions>
    <comparator>Kitchen made product consisted of meat extract and potato extract 150 cc every 3 hours via enteral feeding tube for 7 days</comparator>
    <control>Active</control>
    <interventioncode>Treatment: Other</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>assesment of maastricht index in baseline, third day and 7th day after enteral feeding</outcome>
      <timepoint>baseline , 3 and 7 days after starting enteral feeding</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>evaluation of laboratory parameters such as: hemoglobin, Albumin, blood sugar, cholosterol and Trigleceride</outcome>
      <timepoint>baseline , 3 and 7 days  after starting enteral feeding</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>All inpatients of ICU of shahid rajaii hospital need enteral feeding</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>60</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>diabetic , renal failure, hepatic failure</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>allocation involved contacting the holder of the allocation schedule who was “off-site” or at central administration site.</concealment>
    <sequence>Simple randomisation using a randomisation table from a statistic book</sequence>
    <masking>Blinded (masking used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint>Safety/efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Phase 1</phase>
    <anticipatedstartdate>10/01/2009</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>60</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Closed: follow-up complete</recruitmentstatus>
    <recruitmentcountry>,Outside</recruitmentcountry>
    <recruitmentstate />
    <countryoutsideaustralia>
      <country>Iran, Islamic Republic Of</country>
      <state />
    </countryoutsideaustralia>
  </recruitment>
  <sponsorship>
    <primarysponsortype>University</primarysponsortype>
    <primarysponsorname>Shahid Beheshti University of Medical Sciences</primarysponsorname>
    <primarysponsoraddress>Department of Clinical Pharmacy, Faculty of Pharmacy,Valiasr St,Nyayesh Junction, Tehran, Iran , 1991953381</primarysponsoraddress>
    <primarysponsorcountry>Iran, Islamic Republic Of</primarysponsorcountry>
    <fundingsource>
      <fundingtype>University</fundingtype>
      <fundingname>Shahid Beheshti University of Medical Sciences</fundingname>
      <fundingaddress>Department of Clinical Pharmacy, Faculty of Pharmacy,Valiasr St,Nyayesh Junction, Tehran, Iran , 1991953381</fundingaddress>
      <fundingcountry>Iran, Islamic Republic Of</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname />
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>Maastricht index is an international parameter for assessment of nutritional status in hospitalized patients. This study was designed to compare Maastricht index between patients who received a standard enteral feeding product and kitchen made nutrition in ICU of a teaching hospital. 
Method: A Randomized Clinical trial was done in ICU of shahid Rajaii hospital in Tehran, Iran. 60 patients under enteral feeding enrolled the study and evaluated for 10 days. Patients were randomized to receive fresubin (a standard enteral feeding available in Iran) or kitchen made nutrition that is routine nutrition delivery in most hospitals of Iran. In both groups nasogastric tubes were used for delivery of nutrients. Assessments of patients on the basis of Maastricht index were done at baseline, third day and seventh day after beginning enteral feeding.</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Shahid Beheshti university of Medical sciences ethical committee</ethicname>
      <ethicaddress>Faculty of Pharmacy,Valiasr St,Nyayesh Junction, Tehran, Iran , 1991953381</ethicaddress>
      <ethicapprovaldate>12/12/2008</ethicapprovaldate>
      <hrec />
      <ethicsubmitdate>2/12/2008</ethicsubmitdate>
      <ethiccountry>Iran, Islamic Republic Of</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Mohammad Abbsinazari</name>
      <address>Department of Clinical Pharmacy, Faculty of Pharmacy,Valiasr St,Nyayesh Junction, Tehran, Iran , 1991953381</address>
      <phone>+982188873704</phone>
      <fax>+982188873704</fax>
      <email>farshadpharm@yahoo.com</email>
      <country>Iran, Islamic Republic Of</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Mohammad Abbsinazari</name>
      <address>Department of Clinical Pharmacy, Faculty of Pharmacy,Valiasr St,Nyayesh Junction, Tehran, Iran , 1991953381</address>
      <phone>+982188873704</phone>
      <fax>+982188873704</fax>
      <email>farshadpharm@yahoo.com</email>
      <country>Iran, Islamic Republic Of</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name>Mohammad Abbsinazari</name>
      <address>Department of Clinical Pharmacy, Faculty of Pharmacy,Valiasr St,Nyayesh Junction, Tehran, Iran , 1991953381</address>
      <phone>+982188873704</phone>
      <fax>+982188873704</fax>
      <email>farshadpharm@yahoo.com</email>
      <country>Iran, Islamic Republic Of</country>
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>